Breaking News Instant updates and real-time market news.

CCXI

ChemoCentryx

$11.12

-1.54 (-12.16%)

12:47
08/14/18
08/14
12:47
08/14/18
12:47

ChemoCentryx selloff on competitor downgrade overdone, says Raymond James

CCXI ChemoCentryx
$11.12

-1.54 (-12.16%)

08/14/18
JPMS
08/14/18
DOWNGRADE
Target $15
JPMS
Neutral
ChemoCentryx downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Anupam Rama downgraded ChemoCentryx to Neutral while raising his price target for the shares to $15 from $14. The analyst expects continued progress from the company but finds the stock fairly valued following the recent rally.
07/13/18
BMOC
07/13/18
INITIATION
Target $45
BMOC
Outperform
InflaRx initiated with an Outperform at BMO Capital
As reported earlier, BMO Capital analyst Matthew Luchini initiated InflaRX (IFRX) with an Outperform rating and a price target of $45. The analyst notes that the company's IFX-1 "could be a best-in-class treatment for hidradenitis suppurativa" skin diseas, with initial data suggesting a "better clinical profile" than Humira. Luchini adds that the strength of IFX-1's Phase IIa data de-risks the ongoing Phase IIb trial, also stating that "IFX-1's targeting of C5a could be an advantage over emerging competitor avacopan" made by ChemoCentryx (CCXI).
06/28/18
RAJA
06/28/18
INITIATION
Target $18
RAJA
Strong Buy
ChemoCentryx initiated with a Strong Buy at Raymond James
Raymond James analyst Steven Seedhouse initiated ChemoCentryx with a Strong Buy and $18 price target.
05/16/18
ADAM
05/16/18
INITIATION
Target $17
ADAM
Buy
ChemoCentryx initiated with a Buy at Canaccord
Canaccord analyst Michelle Gilson initiated ChemoCentryx with a Buy rating. The analyst views data from two Phase 2 studies evaluating avacopan as supportive of the company's ongoing Phase 3 study in ANCA-associated vasculitis, boding well for the mid-2019 readout on non-inferiority. She said the pipeline provides upside opportunity as the case study of a patient demonstrating benefit two years out is encouraging. Gilson has a $17 price target on ChemoCentryx shares.

TODAY'S FREE FLY STORIES

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
09/26/18
09/26
10:16
09/26/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBM

IBM

$151.89

2.98 (2.00%)

10:15
09/26/18
09/26
10:15
09/26/18
10:15
Hot Stocks
IBM rises after UBS says buy on AI potential, low public cloud exposure »

In a research note to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 21

    Oct

  • 22

    Oct

  • 03

    Mar

10:15
09/26/18
09/26
10:15
09/26/18
10:15
General news
Breaking General news story  »

Week of 9/21 EIA…

SVMK

SurveyMonkey

$0.00

(0.00%)

10:13
09/26/18
09/26
10:13
09/26/18
10:13
Syndicate
SurveyMonkey indicated to open at $20, IPO priced at $12 »

SurveyMonkey (SVMK)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

BBVA

Banco Bilbao

$6.55

-0.035 (-0.53%)

10:12
09/26/18
09/26
10:12
09/26/18
10:12
Hot Stocks
Banco Bilbao designates CEO Carlos Torres Vila as next chairman »

The board BBVA approved…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 03

    Oct

F

Ford

$9.37

-0.025 (-0.27%)

, VLKAY

Volkswagen

$0.00

(0.00%)

10:10
09/26/18
09/26
10:10
09/26/18
10:10
Periodicals
Ford expands partnership talks with VW, Mahindra to cut costs, Reuters reports »

Ford (F) CEO Jim Hackett…

F

Ford

$9.37

-0.025 (-0.27%)

VLKAY

Volkswagen

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 02

    Oct

SQ

Square

$94.76

-0.64 (-0.67%)

10:10
09/26/18
09/26
10:10
09/26/18
10:10
Options
Heavy trading in Square weekly options as shares fall from record highs »

Heavy trading in Square…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 26

    Nov

ETTX

Entasis Therapeutics

$0.00

(0.00%)

10:03
09/26/18
09/26
10:03
09/26/18
10:03
Syndicate
Entasis Therapeutics opens at $13.45, IPO priced at $15.00 per share »

Entasis Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

WOR

Worthington

$42.88

-3.39 (-7.33%)

10:00
09/26/18
09/26
10:00
09/26/18
10:00
Hot Stocks
Worthington falls -7.4% »

Worthington is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

GPRO

GoPro

$7.25

0.62 (9.35%)

10:00
09/26/18
09/26
10:00
09/26/18
10:00
Options
Active trading in GoPro weekly options as shares spike »

Active trading in GoPro…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATU

Actuant

$27.10

-2.65 (-8.91%)

10:00
09/26/18
09/26
10:00
09/26/18
10:00
Hot Stocks
Actuant falls -7.9% »

Actuant is down -7.9%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

PES

Pioneer Energy

$3.13

-0.325 (-9.42%)

10:00
09/26/18
09/26
10:00
09/26/18
10:00
Hot Stocks
Pioneer Energy falls -8.1% »

Pioneer Energy is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

BFR

BBVA Banco Frances

$12.83

0.63 (5.16%)

10:00
09/26/18
09/26
10:00
09/26/18
10:00
Hot Stocks
BBVA Banco Frances rises 5.4% »

BBVA Banco Frances is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRS

Irsa Inversiones y Representaciones SA

$18.00

1.18 (7.02%)

10:00
09/26/18
09/26
10:00
09/26/18
10:00
Hot Stocks
Irsa Inversiones y Representaciones SA rises 7.3% »

Irsa Inversiones y…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBD

Care Concepts I, Inc.

$24.22

(0.00%)

10:00
09/26/18
09/26
10:00
09/26/18
10:00
Hot Stocks
Care Concepts I, Inc. rises 6.6% »

Care Concepts I, Inc. is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPRO

GoPro

$7.25

0.62 (9.35%)

10:00
09/26/18
09/26
10:00
09/26/18
10:00
Hot Stocks
GoPro rises following analyst upgrade on 'compelling' products »

Shares of GoPro (GPRO)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMNY

Helios and Matheson

$0.02

-0.0015 (-8.06%)

, AMC

AMC Entertainment

$20.05

0.175 (0.88%)

09:56
09/26/18
09/26
09:56
09/26/18
09:56
Hot Stocks
Helios and Matheson sinks as AMC's Stubs A-List surpasses 380,000 members »

Shares of MoviePass…

HMNY

Helios and Matheson

$0.02

-0.0015 (-8.06%)

AMC

AMC Entertainment

$20.05

0.175 (0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 13

    Nov

SCG

Scana

$36.25

0.96 (2.72%)

, ALXN

Alexion

$134.40

5.4 (4.19%)

09:55
09/26/18
09/26
09:55
09/26/18
09:55
Options
Early notable gainers among liquid option names on September 26th »

Notable gainers among…

SCG

Scana

$36.25

0.96 (2.72%)

ALXN

Alexion

$134.40

5.4 (4.19%)

VIAB

Viacom

$33.80

1.32 (4.06%)

NLSN

Nielsen

$28.00

0.795 (2.92%)

GE

General Electric

$11.42

0.15 (1.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 18

    Feb

ABBV

AbbVie

$94.50

0.72 (0.77%)

, VRTX

Vertex

$184.11

1.54 (0.84%)

09:55
09/26/18
09/26
09:55
09/26/18
09:55
Conference/Events
William Blair biotech analysts to hold an analyst/industry conference call »

Biotech Analysts Xu,…

ABBV

AbbVie

$94.50

0.72 (0.77%)

VRTX

Vertex

$184.11

1.54 (0.84%)

ACER

Acer Therapeutics

$30.55

(0.00%)

BHVN

Biohaven Pharmaceutical

$37.47

(0.00%)

CELG

Celgene

$88.38

0.82 (0.94%)

EXEL

Exelixis

$17.38

0.19 (1.11%)

PTLA

Portola Pharmaceuticals

$28.27

0.57 (2.06%)

BMY

Bristol-Myers

$62.20

0.38 (0.61%)

BIIB

Biogen

$342.79

1.21 (0.35%)

AMGN

Amgen

$208.06

1.59 (0.77%)

BLUE

Bluebird Bio

$141.90

(0.00%)

ONCE

Spark Therapeutics

$57.63

0.07 (0.12%)

LOXO

Loxo Oncology

$164.55

-2.25 (-1.35%)

RCKT

Rocket Pharmaceuticals

$25.11

0.01 (0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

  • 26

    Sep

  • 01

    Oct

  • 03

    Oct

  • 04

    Oct

  • 16

    Oct

  • 17

    Oct

  • 17

    Oct

  • 22

    Oct

  • 25

    Oct

  • 29

    Oct

  • 09

    Nov

  • 26

    Nov

  • 27

    Nov

  • 01

    Dec

  • 31

    Dec

  • 14

    Jan

09:55
09/26/18
09/26
09:55
09/26/18
09:55
Conference/Events
House Energy & Commerce Committee to hold a hearing »

The Subcommittee on…

KO

Coca-Cola

$45.79

0.105 (0.23%)

09:55
09/26/18
09/26
09:55
09/26/18
09:55
Conference/Events
Senate Environment and Public Works Committee to hold a hearing »

The Committee holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 28

    Oct

  • 30

    Oct

TWTR

Twitter

$28.85

-0.26 (-0.89%)

, T

AT&T

$33.80

0.04 (0.12%)

09:55
09/26/18
09/26
09:55
09/26/18
09:55
Conference/Events
Senate Commerce, Science & Transportation Committee to hold a hearing »

The Committee holds a…

TWTR

Twitter

$28.85

-0.26 (-0.89%)

T

AT&T

$33.80

0.04 (0.12%)

GOOG

Alphabet

$1,180.39

-4.17 (-0.35%)

CHTR

Charter

$325.69

2.3 (0.71%)

AMZN

Amazon.com

$1,964.97

-9.53 (-0.48%)

AAPL

Apple

$221.94

-0.25 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 04

    Oct

  • 21

    Oct

  • 24

    Oct

  • 25

    Oct

  • 26

    Oct

  • 28

    Oct

  • 06

    Nov

  • 07

    Nov

  • 12

    Nov

  • 03

    Mar

PFE

Pfizer

$44.07

0.27 (0.62%)

, AMGN

Amgen

$208.06

1.59 (0.77%)

09:55
09/26/18
09/26
09:55
09/26/18
09:55
Conference/Events
Drug Information Association to hold a virtual conference »

Biosimilar Reimbursement…

PFE

Pfizer

$44.07

0.27 (0.62%)

AMGN

Amgen

$208.06

1.59 (0.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

  • 26

    Sep

  • 01

    Oct

  • 03

    Oct

  • 03

    Oct

  • 10

    Oct

  • 17

    Oct

  • 22

    Oct

  • 30

    Oct

  • 09

    Nov

AVHI

A.V. Homes

$21.48

(0.00%)

09:55
09/26/18
09/26
09:55
09/26/18
09:55
Conference/Events
A.V. Homes to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 15

    Nov

PTE

PolarityTE

$20.11

-1 (-4.74%)

, COOL

Ticker changed to PTE

$0.00

(0.00%)

09:53
09/26/18
09/26
09:53
09/26/18
09:53
Periodicals
Violations found by FDA at PolarityTE facility, Capitol Forum says »

The FDA send a Form 483…

PTE

PolarityTE

$20.11

-1 (-4.74%)

COOL

Ticker changed to PTE

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.